2 transcripts
MDXG
Earnings call transcript
NASDAQ
2024 Q2
31 Jul 24
dramatically worse as a result of new and intricate schemes designed with the express purpose of self-enrichment by massively overbilling CMS for products
MDXG
Earnings call transcript
NASDAQ
2023 Q4
28 Feb 24
, the tissue can no longer be used for its intended purpose or homologous use.We disagree with this position when it comes to AXIOFILL and do not believe
- Prev
- 1
- Next